GeoWealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Sell |
2,832
-160
| -5% | -$10.3K | 0.01% | 688 |
|
|
2025
Q1 | $190K | Sell |
2,992
-7,254
| -71% | -$460K | 0.01% | 673 |
|
|
2024
Q4 | $682K | Sell |
10,246
-2,320
| -18% | -$154K | 0.02% | 397 |
|
|
2024
Q3 | $877K | Buy |
12,566
+6,671
| +113% | +$466K | 0.03% | 331 |
|
|
2024
Q2 | $382K | Buy |
5,895
+54
| +0.9% | +$3.5K | 0.02% | 505 |
|
|
2024
Q1 | $378K | Buy |
5,841
+945
| +19% | +$61.2K | 0.01% | 508 |
|
|
2023
Q4 | $322K | Buy |
4,896
+604
| +14% | +$39.7K | 0.03% | 396 |
|
|
2023
Q3 | $245K | Buy |
4,292
+226
| +6% | +$12.9K | 0.03% | 263 |
|
|
2023
Q2 | $250K | Buy |
4,066
+1,353
| +50% | +$83.2K | 0.03% | 230 |
|
|
2023
Q1 | $171K | Buy |
2,713
+384
| +16% | +$24.2K | 0.02% | 217 |
|
|
2022
Q4 | $147K | Sell |
2,329
-584
| -20% | -$36.9K | 0.02% | 261 |
|
|
2022
Q3 | $172K | Buy |
+2,913
| New | +$172K | 0.02% | 249 |
|